First second forced expiratory volume accounts for the percentage of FVC (FEV1%).
第一秒用力呼气量占用力肺活量的百分率(FEV1 %)。
The forced expiratory volume in one second (FEV1) was measured before and after inhalation.
测定所有患者用药前后第1秒用力呼气量（FEV1）变化。
In order to get rid of the effect of baseline FEV1 changes induced by atropine inhalation, covariance analysis was used.
为了排除吸入阿托品后基础FEV_1变化的影响，采用协方差分析法进行检验。
Maximum forced expiratory volume in 1 second (FEV1) was measured, and patients' self-reported improvement ratings were recorded.
测量最大1秒钟用力呼气量（FEV1），并记录病人的自我报告改善等级评定。
Pulmonary function tests(PFT), including forced vital capacity(FVC), forced the first second of expiratory volume (FEV1) and FEV1/FVC.
肺功能检查结果。包括用力肺活量（FVC），第一秒时间肺活量（FEV1）和一秒率（FEV1／FVC）等。
Indeed, the PDS performed better than FEV1, peak expiratory flow rate, and fraction of exhaled nitric oxide in predicting outcomes after discharge.
事实上，PDS要比FEV1、呼吸峰流速和氧化亚氮呼出率更能预测出院后的结果。
Results There was a linear regression relationship between the course of the disease, smoking index of asthma patients and the improvement rate of FEV1.
结果 1。哮喘患者病程、吸烟指数与支气管舒张试验中FEV1改善率有线性回归关系；
Women with fast FEV1 decline had a 31% increase in probability of elevated hs-CRP versus 25% in men, when weight gain and other variables were controlled for.
在体重增加和其他变量可控制的情况下，女性FEV1快速下降者hs-CRP上升的可能性是31%，而男性是25%。
Result:The FEV1 and the percentage of FEV1 in two groups after treatment was superior to that before treatment, and there was significant difference in them respectively(P<0.05).
结果：两组患者FEV1、FEV1百分比均较治疗前改善，治疗前后比较差异具有统计学意义（P〈0.05）；
Among the 39 patients who completed the study, albuterol resulted in a 20% increase in FEV1, as compared with approximately 7% with each of the other three interventions (P<0.001).
结果 在39例完成研究的病人中，沙丁胺醇导致FEV1增加20%，与之相比，其他3 种干预的每一种大约增加7%（P＜0.001）。
Although albuterol, but not the two placebo interventions, improved FEV1 in these patients with asthma, albuterol provided no incremental benefit with respect to the self-reported outcomes.
结论在这些哮喘病人中，尽管沙丁胺醇(而不是两种安慰剂干预)可改善FEV1，但沙丁胺醇在自我报告的转归方面没有提供额外的益处。
Results Symptoms and pulmonary function (FEV1, MMEF) of the patients were improved obviously in the treated group. While the observed indexes were not significantly changed in the control group.
结果治疗组病人的症状及肺功能(FEV_1、MMEF)有明显改善，而对照组各项观察指标均无显著变化。
Among patients assigned to take budesonide, smokers experienced a mean decline of 192.4 ml in post-bronchodilator FEV1 over the study period while non-smokers experienced a mean decline of 134.3 ml.
在研究期间，被指定接受布地奈德的吸烟患者使用支气管扩张器后FEV1值平均下降192.4ml，而非吸烟者平均下降134.3 ml。
Methods: Healthy, athletic subjects who are suspected of having exercise-induced bronchospasm were recruited, and FEV1 values were determined following provocative airway challenges with methacholine.
方法：受试的对象为可疑的运动诱导的支气管痉挛的健康、体格健壮的个体，用乙酰胆碱激发气道反应后，测定一秒钟用力呼气量。
Methods: Healthy, athletic subjects who are suspected of having exercise-induced bronchospasm were recruited, and FEV1 values were determined following provocative airway challenges with methacholine.
方法：受试的对象为可疑的运动诱导的支气管痉挛的健康、体格健壮的个体，用乙酰胆碱激发气道反应后，测定一秒钟用力呼气量。
应用推荐